Publicaciones en colaboración con investigadores/as de Instituto de Investigación del Hospital de La Princesa (26)

2026

  1. Biological therapies for inflammatory pouch disorders: insights and outcomes from the RESERVO study of GETECCU

    Therapeutic Advances in Gastroenterology, Vol. 19

  2. Evaluation of temporal muscle thickness in subjects with acromegaly: a follow-up study

    Therapeutic Advances in Endocrinology and Metabolism, Vol. 17

  3. Improving the multidimensional scoring systems in bronchiectasis: the role of cellular biomarkers

    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, Vol. 30, Núm. 1, pp. 40-42

  4. Safety of sonidegib in elderly patients with locally advanced basal cell carcinoma: A multicentre study

    Journal of the European Academy of Dermatology and Venereology

  5. Trends in Hepatitis C Virus Infection Prevalence Among People With HIV in Spain Over 2 Decades (2002-2023)

    Clinical Infectious Diseases, Vol. 82, Núm. 3, pp. e511-e520

2025

  1. Bleeding Risk in Elderly Patients Undergoing Percutaneous Coronary Intervention: A Comprehensive Review

    Journal of Clinical Medicine, Vol. 14, Núm. 4

  2. Bronchopulmonary colonization patterns in Spanish people with cystic fibrosis: Results of a national multicentre study

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 43, Núm. 6, pp. 309-316

  3. Comparative Efficacy and Immunogenicity of Infliximab and Adalimumab in Crohn’s Disease: A Prospective Cohort Study

    Medicina (Lithuania), Vol. 61, Núm. 12

  4. Comparative effectiveness of long-acting injectable versus oral antipsychotic medication after a first episode of psychosis

    Nature Mental Health, Vol. 3, Núm. 4, pp. 421-428

  5. Effect of N-Acetylcysteine on Bronchiectasis in a Real-life Study. Data From the Spanish RIBRON Registry

    Archivos de Bronconeumologia, Vol. 61, Núm. 4, pp. 196-202

  6. Epidemiology and Risk Factors for HCV Infection Among MSM With or at Risk of HIV in Madrid (2022–2024)

    Open Forum Infectious Diseases, Vol. 12, Núm. 12

  7. Geriatric conditions and invasive management in frail patients with NSTEMI. A subgroup analysis of a randomized clinical trial

    Revista Espanola de Cardiologia, Vol. 78, Núm. 4, pp. 319-326

  8. Multi-center Assessment of DLL3 Expression by Immunohistochemistry in Medullary Thyroid Carcinoma

    Endocrine Pathology, Vol. 36, Núm. 1

  9. Persistent Blood Eosinophilia and Eosinopenia: Relationship with Outcomes in Bronchiectasis

    Archivos de Bronconeumologia, Vol. 61, Núm. 8, pp. 484-489

  10. The DEPRE’5 study: pragmatic, multicentre, five-arm, parallel-group randomised controlled trial with blinded assessment to compare treatment strategies in major depression after a failed selective serotonin reuptake inhibitor treatment

    British Journal of Psychiatry, Vol. 227, Núm. 5, pp. 748-755

  11. Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU

    Digestive and Liver Disease, Vol. 57, Núm. 2, pp. 566-573

  12. What is the optimal dose of N-acetylcysteine in adult patients with bronchiectasis?—data from the RIBRON registry

    Journal of Thoracic Disease, Vol. 17, Núm. 10, pp. 9003-9012

2024

  1. A Phase III Randomized Controlled Trial of Plitidepsin, a Marine-Derived Compound, in Hospitalized Adults With Moderate COVID-19

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 79, Núm. 4, pp. 910-919

  2. Consensus on the approach to hydrosaline overload in acute heart failure. SEMI/SEC/S.E.N. recommendations

    Revista Espanola de Cardiologia, Vol. 77, Núm. 7, pp. 556-565

  3. Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU

    Therapeutic Advances in Gastroenterology, Vol. 17